BioSpace News Archive

Drug Development

IRLAB’s Drug Candidate IRL757 is Phase I Ready

IRLAB Therapeutics AB announced that the company’s drug candidate IRL757 has completed all preclinical studies and development work necessary to start Phase I.

December 21, 2023
·
3 min read
Business

LIfT BioSciences appoints Dr Bo Rode Hansen and Dr Marco Gottardis to its Board of Directors

LIfT BioSciences, a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy, announces the appointments of Dr Bo Rode Hansen PhD, MBA and Dr Marco Gottardis, PhD as Non-Executive Directors of its Board.

December 21, 2023
·
4 min read
Drug Development

Ocugen Gains FDA Alignment on Key Aspects of OCU400—Modifier Gene Therapy—Pivotal Phase 3 Study Design

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN) today announced that the Company received alignment from FDA on key aspects of the Phase 3 clinical trial design to assess the safety and efficacy of OCU400 in patients with RHO and other gene mutations associated with Retinitis Pigmentosa (RP).

December 21, 2023
·
4 min read
Pharm Country

HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences

HOOKIPA Pharma Inc. announced that Gilead Sciences has purchased 15 million shares of HOOKIPA’s common stock for approximately $21.25 million, at a price of $1.4167 per share.

December 21, 2023
·
6 min read
Pluri and Bar-Ilan University to Develop PLX Cells for the Treatment of Cocaine Addiction

Pluri Inc. announced it has signed an agreement assigning the joint patent rights to develop Pluri’s PLX cells in the treatment of cocaine addiction, to BIRAD–Research & Development Company Ltd., the commercial arm of Bar-Ilan University.

December 21, 2023
·
7 min read
Pharm Country

Carisma Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Carisma Therapeutics Inc. today announced that the company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024.

December 21, 2023
·
1 min read
Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024

Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd., is gearing up for participation in the JP Morgan 42nd Annual Healthcare Week, scheduled to run from January 8 to 11, 2024, in San Francisco.

December 21, 2023
·
2 min read
Business

Exscientia Announces Expansion of its Current Collaboration with Sanofi to Include Existing Exscientia Programme

Exscientia plc announced that Sanofi is adding a new discovery stage programme identified and initially advanced by Exscientia into the current collaboration.

December 21, 2023
·
3 min read
Biotech Bay

ZAP Surgical Announces Multi-System Order, Broadening Its Brain Tumor Treatment Footprint in the United Kingdom, Germany, and Spain

ZAP Surgical today announced that Mercurius Health has entered into a master purchase agreement for five ZAP-X® Gyroscopic Radiosurgery® systems.

December 21, 2023
·
4 min read
Poxel Provides Corporate Update - December 21, 2023

POXEL SA, a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis and rare metabolic disorders, provides a corporate update.

December 21, 2023
·
5 min read